D.C Piper

3.0k total citations
23 papers, 1.5k citations indexed

About

D.C Piper is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, D.C Piper has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Cognitive Neuroscience and 5 papers in Molecular Biology. Recurrent topics in D.C Piper's work include Neuroscience and Neuropharmacology Research (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Sleep and Wakefulness Research (6 papers). D.C Piper is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Sleep and Wakefulness Research (6 papers). D.C Piper collaborates with scholars based in United Kingdom, United States and Australia. D.C Piper's co-authors include Neil Upton, Martin Smith, A. Jackie Hunter, N. Upton, Jackie Cilia, David R. Thomas, Thomas P. Blackburn, G.A. Kennett, John E. Blundell and R.J. Rodgers and has published in prestigious journals such as British Journal of Pharmacology, SLEEP and Psychopharmacology.

In The Last Decade

D.C Piper

23 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.C Piper United Kingdom 17 731 645 588 450 355 23 1.5k
N. Upton United Kingdom 24 826 1.1× 758 1.2× 916 1.6× 452 1.0× 492 1.4× 38 2.2k
Rick L. Pieschl United States 14 468 0.6× 877 1.4× 513 0.9× 160 0.4× 228 0.6× 25 1.3k
Héctor Jantos Uruguay 24 998 1.4× 661 1.0× 539 0.9× 307 0.7× 191 0.5× 50 1.5k
Mark Duxon United Kingdom 17 390 0.5× 218 0.3× 782 1.3× 155 0.3× 410 1.2× 24 1.3k
Claude Gottesmann France 28 1.6k 2.2× 476 0.7× 1.2k 2.0× 559 1.2× 466 1.3× 96 2.4k
A. Ahnaou Belgium 25 664 0.9× 269 0.4× 717 1.2× 120 0.3× 365 1.0× 58 1.4k
Jane E. Cluderay United Kingdom 12 796 1.1× 1.1k 1.7× 429 0.7× 431 1.0× 468 1.3× 14 1.7k
James R. Shoblock United States 16 301 0.4× 232 0.4× 539 0.9× 159 0.4× 394 1.1× 23 1.1k
Stephen R. Morairty United States 20 1.1k 1.4× 820 1.3× 663 1.1× 652 1.4× 415 1.2× 34 1.7k
Sándor Kántor Hungary 16 421 0.6× 221 0.3× 561 1.0× 154 0.3× 197 0.6× 22 957

Countries citing papers authored by D.C Piper

Since Specialization
Citations

This map shows the geographic impact of D.C Piper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.C Piper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.C Piper more than expected).

Fields of papers citing papers by D.C Piper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.C Piper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.C Piper. The network helps show where D.C Piper may publish in the future.

Co-authorship network of co-authors of D.C Piper

This figure shows the co-authorship network connecting the top 25 collaborators of D.C Piper. A scholar is included among the top collaborators of D.C Piper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.C Piper. D.C Piper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Falkner, Nickolas, Rebecca Vivian, D.C Piper, & Katrina Falkner. (2014). Increasing the effectiveness of automated assessment by increasing marking granularity and feedback units. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 9–14. 32 indexed citations
3.
Smith, M.I, D.C Piper, Mark Duxon, & N. Upton. (2003). Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat. Neuroscience Letters. 341(3). 256–258. 63 indexed citations
4.
Smith, M.I, D.C Piper, Mark Duxon, & N. Upton. (2002). Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile. Pharmacology Biochemistry and Behavior. 71(4). 599–605. 31 indexed citations
5.
Rodgers, R.J., Jason C. G. Halford, D.C Piper, et al.. (2001). SB‐334867, a selective orexin‐1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin‐A in rats. European Journal of Neuroscience. 13(7). 1444–1452. 196 indexed citations
6.
Cilia, Jackie, D.C Piper, N. Upton, & Jim J. Hagan. (2001). Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule. Psychopharmacology. 155(2). 135–143. 17 indexed citations
7.
Hagan, Jim J., Gary Price, Philip D. Jeffrey, et al.. (2000). Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist. British Journal of Pharmacology. 130(3). 539–548. 254 indexed citations
8.
Piper, D.C, Neil Upton, Martin Smith, & A. Jackie Hunter. (2000). The novel brain neuropeptide, orexin‐A, modulates the sleep–wake cycle of rats. European Journal of Neuroscience. 12(2). 726–730. 282 indexed citations
9.
Rodgers, R.J., et al.. (2000). Dose–response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regulatory Peptides. 96(1-2). 71–84. 96 indexed citations
10.
Cilia, Jackie, D.C Piper, N. Upton, & J.J. Hagan. (1998). A comparison of rectal and subcutaneous body temperature measurement in the common marmoset. Journal of Pharmacological and Toxicological Methods. 40(1). 21–26. 37 indexed citations
11.
Cilia, Jackie & D.C Piper. (1997). Marmoset Conspecific Confrontation: An Ethologically-Based Model of Anxiety. Pharmacology Biochemistry and Behavior. 58(1). 85–91. 48 indexed citations
12.
Kennett, G.A., Martyn Wood, Fiona Bright, et al.. (1996). In vitroandin vivoprofile of SB 206553, a potent 5‐HT2C/5‐HT2Breceptor antagonist with anxiolytic‐like properties. British Journal of Pharmacology. 117(3). 427–434. 211 indexed citations
13.
Kennett, G.A., Fiona P. Bailey, D.C Piper, & Thomas P. Blackburn. (1995). Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety. Psychopharmacology. 118(2). 178–182. 51 indexed citations
14.
Rahman, Shirley K., D.C Piper, & Frank D. King. (1994). Central & Peripheral Nervous System: 5-HT3receptor antagonists. Expert Opinion on Therapeutic Patents. 4(6). 669–680. 5 indexed citations
15.
Blackburn, Thomas P., Gordon S. Baxter, G.A. Kennett, et al.. (1993). BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties. Psychopharmacology. 110(3). 257–264. 54 indexed citations
16.
Forbes, Ian T., et al.. (1993). Synthesis and potential anxiolytic activity of 4-amino-pyrido[2,3-b]indoles. Bioorganic & Medicinal Chemistry Letters. 3(10). 1941–1946. 28 indexed citations
17.
Cutler, Margaret G. & D.C Piper. (1990). Chronic administration of the 5-HT3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil. Psychopharmacology. 101(2). 244–249. 18 indexed citations
18.
Gardner, Colin & D.C Piper. (1982). Effects of agents which enhance GABA-mediated neurotransmission on licking conflict in rats and exploration in mice. European Journal of Pharmacology. 83(1-2). 25–33. 48 indexed citations
19.
Piper, D.C, Brian S. Meldrum, & Colin Gardner. (1981). Anticonvulsant activity of a new 1,4‐benzodiazepine in rodents and the baboon Papio papio. Drug Development Research. 1(1). 77–82. 1 indexed citations
20.
James, G. Watson & D.C Piper. (1978). A method for evaluating potential hypnotic compounds in rats. Journal of Pharmacological Methods. 1(2). 145–154. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026